Activity content starts in:
Industry Webcast
Opportunities to Reduce the Rising Tide of Cardiovascular Events Through Better Management of LDL-CholesterolIndustry Webcast Sponsored by Family Heart Foundation; Not for CME/CE Credit
Cardiovascular disease is still the leading cause of death in the United States and the trend is moving in the wrong direction, with 2022 setting a record for deaths due to cardiovascular disease in the US at close to 1 million. LDL-cholesterol is a major modifiable cardiovascular risk factor which continues to be poorly controlled.
The Family Heart Foundation is a non-profit organization dedicated to research, education, and advocacy and as part of our ongoing research efforts, we have examined the state of LDL-C control among 38M Americans at high and very high-risk for cardiovascular disease in the proprietary Family Heart Database. This session will provide an update on current LDL-C treatment guidelines and focus on key findings and insights from an analysis of the Family Heart database.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 3/5/2025
Expiration Date: 3/5/2025
Topics
Faculty
Faculty
Fatima Rodriguez, MD, MPH
Associate Professor, Cardiovascular Medicine
Section Chief, Preventive Cardiology
Stanford University School of Medicine
Supporters and Partners
Industry Sponsor
Family Heart Foundation
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.